A Comprehensive Review of the Epidemiology, Pathophysiology, Risk Factors, and Treatment Strategies for Retinoblastoma
Diseases · 19.09.2025 · 13 (9) · 307
DOI: 10.3390/diseases13090307 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Diseases, online erschienen am 19.09.2025. Verfasst von Alpana Kumari und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Optometry, University Institute of Allied Health Sciences, Chandigarh University, Gharuan, Mohali 140413, Punjab, India. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The retinoblastoma gene (RB1), which is located on chromosome 13q14.2, is mutated in retinoblastoma (RB), the most common malignant intraocular tumor in children. About 8000 new cases of retinoblastoma are diagnosed globally each year, accounting for approximately 1 in 17,000 live births. RB is prototypically considered hereditary by nature as thirty to forty percent of cases have autosomal dominant inheritance, and the remaining sixty to seventy percent have non-inherited sporadic inheritance. RB is the most treatable juvenile malignancy, with a high percentage of survival; nevertheless, advanced tumors restrict the amount of globe salvage and are frequently linked to high-risk histological characteristics that indicate spread. Investigating the disease’s molecular causes has also helped to understand its subsequent processes, which has resulted in the identification of biomarkers and relevant targeted treatments. Additionally, advancements in molecular biology techniques facilitated the creation of effective strategies for early disease detection, genetic counseling, and prevention. In the present review, we discuss the risk factors, epidemiology, pathology, and therapeutic approaches for retinoblastoma. We specifically focus on the genetic and molecular characteristics of retinoblastoma, including mutations that cause key signaling pathways involved in the DNA repair, cellular plasticity, and cell proliferation to become dysregulated.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Optometry, University Institute of Allied Health Sciences, Chandigarh University, Gharuan, Mohali 140413, Punjab, India.
- Chicago DLS Inc., Chicago, IL 60652, USA.
- Department of Biochemistry, U.P. University of Medical Sciences, Saifai, Etawah 206130, Uttar Pradesh, India.
- Department of Biochemistry, Symbiosis Medical College for Women, Symbiosis International (Deemed University), Pune 412115, Maharashtra, India.
- Department of Medical Lab Sciences, Rayat-Bahra University, Mohali 140104, Punjab, India.
- Department of Pathology & Laboratory Medicine, School of Medicine, University of Ottawa, Ottawa, ON K1N 6N5, Canada.
ORCID-Profile: Alpana Kumari, Suresh Babu Kondaveeti, Vivek Kumar Garg, Katrin Sak, Vikas Yadav
Zitieren
APA
Kumari, A., Singh, S. P., Kumar, P., Kondaveeti, S. B., Garg, V. K., Kaur, R., Buttar, H. S., Sak, K., Yadav, K., & Yadav, V. (2025). A Comprehensive Review of the Epidemiology, Pathophysiology, Risk Factors, and Treatment Strategies for Retinoblastoma. Diseases, 13(9), 307. https://doi.org/10.3390/diseases13090307
Vancouver
Kumari A, Singh SP, Kumar P, Kondaveeti SB, Garg VK, Kaur R, et al. A Comprehensive Review of the Epidemiology, Pathophysiology, Risk Factors, and Treatment Strategies for Retinoblastoma. Diseases. 2025;13(9):307. doi:10.3390/diseases13090307
BibTeX
@article{Kumari2025,
author = {Kumari, Alpana and Singh, Sarav Paul and Kumar, Pankaj and Kondaveeti, Suresh Babu and Garg, Vivek Kumar and Kaur, Rabdeep and Buttar, Harpal Singh and Sak, Katrin and Yadav, Kiran and Yadav, Vikas},
title = {A Comprehensive Review of the Epidemiology, Pathophysiology, Risk Factors, and Treatment Strategies for Retinoblastoma},
journal = {Diseases},
year = {2025},
volume = {13},
number = {9},
pages = {307},
doi = {10.3390/diseases13090307}
}
EUVIMED